Australian Pharmaceutical Patents Review Draft Report Critical Of Patent Extensions, R&D Funding
The Australian Pharmaceutical Patents Review yesterday issued its draft report, recommending that the Australian government reduce pharmaceutical patent extension terms and use estimated savings to subsidise research and development.
